The global tissue diagnostics market is projected to grow from $6.86 billion in 2026 to $9.33 billion by 2031, at a CAGR of 6.35%. Growth is driven by rising cancer prevalence, increased adoption of precision medicine, and advancements in digital pathology and biomarker testing. North America leads the market, while Asia-Pacific is a fast-growing region due to expanding healthcare infrastructure and investments. The market benefits from innovations in AI-assisted diagnostics, immunohistochemistry, and molecular diagnostics, supporting personalized cancer treatment and early disease detection.
Ukraine has launched a nationwide cross-telecom identity infrastructure integrating major operators Kyivstar, Vodafone Ukraine, lifecell, and Ukrtelecom. This system uses myGaru technology to create a privacy-preserving environment where telecom iden...
UP Fintech Holding Limited will report its financial results for the first quarter ending March 31, 2026, on June 2 before the U.S. market opens. The company will hold a live earnings conference call at 8:00 AM U.S. Eastern Time, providing investors ...
Wolters Kluwer repurchased 26,465 of its ordinary shares between May 14 and May 20, 2026, spending €1.6 million at an average price of €61.84 per share. This is part of its ongoing 2026 share buyback program, which aims to repurchase up to €500 milli...
Audiencerate Ltd appointed Riccardo Fabbri as Chief Technology Officer to spearhead AI-driven platform development for Italian SMEs and global media agencies. Fabbri brings over 20 years of experience in software and cloud architecture, having co-fou...
Audiencerate Ltd has appointed Riccardo Fabbri as Chief Technology Officer to spearhead the development of AI infrastructure integrating first-party and third-party data. This move supports the expansion of Audiencerate's platforms for Italian SMEs, ...
